Abstract
Potential genetic treatments for many generalized central nervous system (CNS) diseases require transgene expression throughout the CNS. Using oxidant stress and apoptosis caused by HIV-1 envelope gp120 as a model, we studied pan-CNS neuroprotective gene delivery into the cisterna magna (CM). Recombinant SV40 vectors carrying Cu/Zn superoxide dismutase or glutathione peroxidase were injected into rat CMs following intraperitoneal administration of mannitol. Sustained transgene expression was seen in neurons throughout the CNS. On challenge, 8 weeks later with gp120 injected into the caudate putamen, significant neuroprotection was documented. Thus, intracisternal administration of antioxidant-carrying rSV40 vectors may be useful in treating widespread CNS diseases such as HIV-1-associated neurocognitive disorders characterized by oxidative stress.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Akli S, Caillaud C, Vigne E, Stratford-Perricaudet LD, Poenaru L, Perricaudet M et al. Transfer of a foreign gene into the brain using adenovirus vectors. Nat Genet 1993; 3: 224–228.
Betz AL, Shakui P, Davidson BL . Gene transfer to rodent brain with recombinant adenoviral vectors: effects of infusion parameters, infectious titer, and virus concentration on transduction volume. Exp Neurol 1998; 150: 136–142.
Wu P, Phillips MI, Bui J, Terwilliger EF . Adeno-associated virus vector-mediated transgene integration into neurons and other nondividing cell targets. J Virol 1998; 72: 5919–5926.
McCown TJ, Xiao X, Li J, Breese GR, Samulski RJ . Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector. Brain Res 1996; 713: 99–107.
Naldini L, Blomer U, Gage FH, Trono D, Verma IM . Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci USA 1996; 93: 11382–11388.
Kordower JH, Emborg ME, Bloch J, Ma SY, Chu Y, Leventhal L et al. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science 2000; 290: 767–773.
Bosch A, Perret E, Desmaris N, Trono D, Heard JM . Reversal of pathology in the entire brain of mucopolysaccharidosis type VII mice after lentivirus-mediated gene transfer. Hum Gene Ther 2000; 11: 1139–1150.
Skorupa AF, Fisher KJ, Wilson JM, Parente MK, Wolfe JH . Sustained production of beta-glucuronidase from localized sites after AAV vector gene transfer results in widespread distribution of enzyme and reversal of lysosomal storage lesions in a large volume of brain in mucopolysaccharidosis VII mice. Exp Neurol 1999; 160: 17–27.
Louboutin JP, Reyes BAS, Agrawal L, van Bockstaele EJ, Strayer DS . Strategies for CNS-directed gene delivery: in vivo gene transfer to the brain using SV40-derived vectors. Gene Therapy 2007; 14: 939–949.
Louboutin JP, Marusich E, Fisher-Perkins J, Dufour J, Bunnell BA, Strayer DS . Gene transfer to the Rhesus monkey brain using SV40-derived vectors is durable and safe. Gene Therapy 2011; e-pub ahead of print 3 March 2011; doi:10.1038/gt.2011.13.
Louboutin JP, Chekmasova AA, Marusich E, Chowdhury JR, Strayer DS . Efficient CNS gene delivery by intravenous injection. Nat Methods 2010; 7: 905–907.
Louboutin JP, Agrawal L, Reyes BAS, van Bockstaele EJ, Strayer DS . Protecting neurons from HIV-1 gp120-induced oxidant stress using both localized intracerebral and generalized intraventricular administration of antioxidant enzymes delivered by SV40-derived vectors. Gene Therapy 2007; 14: 1650–1661.
Agrawal L, Louboutin JP, Reyes BAS, van Bockstaele EJ, Strayer DS . Antioxidant enzyme gene delivery to protect from HIV-1 gp120-induced neuronal apoptosis. Gene Therapy 2006; 13: 1645–1656.
Agrawal L, Louboutin JP, Strayer DS . Preventing HIV-1 Tat-induced neuronal apoptosis using antioxidant enzymes: mechanistic and therapeutic implications. Virology 2007; 363: 462–472.
Louboutin JP, Reyes BAS, Agrawal L, van Bockstaele EJ, Strayer DS . HIV-1 gp120-induced neuroinflammation: relationship to neuron loss and protection by rSV40-delivered antioxidant enzymes. Exp Neurol 2010; 221: 231–245.
Louboutin JP, Reyes BAS, Agrawal L, van Bockstaele EJ, Strayer DS . Blood-brain barrier abnormalities caused by exposure to HIV-1 gp120-protection by gene delivery of antioxidant enzymes. Neurobiol Dis 2010; 38: 313–325.
Louboutin JP, Agrawal L, Reyes BAS, van Bockstaele EJ, Strayer DS . HIV-1 gp120-induced injury to the blood-brain barrier: role of metalloproteinases 2 and 9 and relationship to oxidative stress. J Neuropathol Exp Neurol 2010; 69: 801–816.
Turchan J, Pocernich CB, Gairola C, Chauhan A, Schifitto G, Butterfield DA et al. Oxidative stress in HIV demented patients and protection ex vivo with novel antioxidants. Neurology 2003; 60: 307–314.
McArthur JC, Brew BJ, Nath A . Neurological complications of HIV infection. Lancet Neurol 2005; 4: 543–555.
Mattson MP, Haughey NJ, Nath A . Cell death in HIV dementia. Cell Death Diff 2005; 12: 893–904.
Strayer DS . Gene therapy using SV40-derived vectors: what does the future hold? J Cell Physiol 1999; 181: 375–384.
Cordelier P, Calarota SA, Pomerantz RJ, Xiaoshan J, Strayer DS . Inhibition of HIV-1 in the central nervous system by IFN-alpha2 delivered by an SV40 vector. J Interferon Cytokine Res 2003; 23: 477–488.
Cordelier P, Van Bockstaele E, Calarota SA, Strayer DS . Inhibiting AIDS in the central nervous system: gene delivery to protect neurons from HIV. Mol Ther 2003; 7: 801–810.
Cordelier P, Strayer DS . Using gene delivery to protect HIV-susceptible CNS cells: inhibiting HIV replication in microglia. Virus Res 2006; 118: 87–97.
Ghodsi A, Stein C, Derksen T, Martins I, Anderson RD, Davidson BL . Systemic hyperosmolarity improves beta-glucuronidase distribution and pathology in murine MPS VII brain following intraventricular gene transfer. Exp Neurol 1999; 160: 109–116.
Fu H, Muenzer J, Samulski RJ, Breese G, Sifford J, Zeng X et al. Self-complementary adeno-associated virus serotype 2 vector: global distribution and broad dispersion of AAV-mediated transgene expression in mouse brain. Mol Ther 2003; 6: 911–917.
Mastakov MY, Baer K, Xu R, Fitzsimons H, During MJ . Combined injection of rAAV with mannitol enhances gene expression in the rat brain. Mol Ther 2001; 3: 225–232.
Bourgoin C, Emiliani C, Kremer EJ, Gelot A, Tancini B, Gravel RA et al. Widespread distribution of β-hexosaminidase activity in the brain of a Sandhoff mouse model after coinjection of adenoviral vector and mannitol. Gene Ther 2003; 10: 1841–1849.
Burger C, Nguyen FN, Deng J, Mandel RJ . Systemic mannitol-induced hyperosmolarity amplifies rAAV2-mediated striatal transduction to a greater extent than local co-infusion. Mol Ther 2005; 11: 327–331.
Nakane H, Chu Y, Faraci FM, Oberley LW, Heistad DD . Gene transfer of extracellular superoxide dismutase increases superoxide dismutase activity in cerebrospinal fluid. Stroke 2001; 32: 184–189.
Watanabe Y, Chu Y, Andresen JJ, Nakane H, Faraci FM, Heistad DD . Gene transfer of extracellular superoxide dismutase reduces cerebral vasospasm after subarachnoid hemorrhage. Stroke 2003; 34: 434–440.
Yamaguchi M, Zhou C, Heistad DD, Watanabe Y, Zhang JH . Gene transfer of extracellular superoxide dismutase failed to prevent cerebral vasospasm after experimental subarachnoid hemorrhage. Stroke 2004; 35: 2512–2517.
Shimamura M, Sato N, Oshima K, Aoki M, Kurinami H, Waguri S et al. Novel therapeutic strategy to treat brain ischemia. Overexpression of hepatocyte growth factor gene reduced ischemic injury without cerebral edema in rat model. Circulation 2004; 109: 424–431.
Strayer DS, Kondo R, Milano J, Duan LX . Use of SV40-based vectors to transduce foreign genes to normal human peripheral blood mononuclear cells. Gene Ther 1997; 4: 219–225.
Strayer DS, Lamothe M, Wei D, Milano J, Kondo R . Generation of recombinant SV40 vectors for gene transfer. SV40 protocols. In: Raptis L (ed). Methods in Molecular Biology, vol. 165. Humana Press: Totowa, NJ, 2001, pp 103–117.
Sauter BV, Parashar B, Chowdhury NR, Kadakol A, Ilan Y, Singh H et al. A replication-deficient rSV40 mediates liver-directed gene transfer and a long-term amelioration of jaundice in gunn rats. Gastroenterology 2000; 119: 1348–1357.
Nosheny RL, Bachis A, Acquas E, Mocchetti I . Human immunodeficiency virus type 1 glycoprotein gp120 reduces the levels of brain-derived neurotrophic factor in vivo: potential implication for neuronal cell death. Eur J Neurosci 2004; 20: 2857–2864.
Mandel RJ, Rendahl KG, Spratt SK, Snyder RO, Cohen LK, Leff SE . Characterization of intrastriatal recombinant adeno-associated virus-mediated gene transfer of human tyrosine hydroxylase and human GTP-cyclohydrolase I in a rat model of Parkinson's disease. J Neurosci 1998; 18: 4271–4284.
Acknowledgements
This work was supported by NIH grants MH69122 and MH70287.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Louboutin, JP., Reyes, B., Agrawal, L. et al. Intracisternal rSV40 administration provides effective pan-CNS transgene expression. Gene Ther 19, 114–118 (2012). https://doi.org/10.1038/gt.2011.75
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/gt.2011.75